STAT6 and neoplasm: They released M2-targeted antagonists after exposure to the acidic tumor microenvironment, co-delivering inhibitors like STAT6 to effectively achieve M2-to-M1 repolarization, thereby inhibiting tumor growth and metastasis (60).